Monday, September 9, 2024, 8:00-9:30
Session: »Mechanistic studies in respiratory infection«
"Acetate inhibits Pseudomonas aeruginosa growth and reduces inflammatory responses to infection in primary human lung tissue ex vivo"
Speaker: Franziska Dahlmann
Monday, September 9, 2024, 12:30-14:00
Session: Novel insights in the pathogenesis of pulmonary fibrosis
"Understanding the Dynamics of Pro-Fibrotic Biomarkers in PCLS: Implications for Pre-clinical Studies"
Speaker: Lena Willmer
Tuesday, September 10, 2024, 12:30-14:00
Session: Developing and assessing treatments for respiratory infection
Antiviral RNAi inhalation inhibits human parainfluenza infection ex vivo and in vivo
Speaker: Philippe Vollmer Barbosa
Advanced in vitro and ex vivo models provide a suitable platform for the evaluation of antiviral small molecules against human parainfluenza virus 3
Speaker: Fabian Röpken
Tuesday, September 10, 2024, 8:00-9:30
Session: New aspects of lung function, inhalers and clinical management for asthma and COPD
A novel macrolide, EP395, in a LPS challenge in healthy volunteers
Speaker: Jens Hohlfeld